Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ PCED1A Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA562248
Description
Immunogen sequence: LPPPIPGPNP HGQHWGPVVH RGMPRYVPNS PYHVRRMGGP CRQRLRHSER LIHTYKLDRR PPAHS Highest antigen sequence identity to the following orthologs: Mouse - 74%, Rat - 74%.
The protein encoded by this gene is a member of the GDSL/SGNH superfamily. Members of this family are hydrolytic enzymes with esterase and lipase activity and broad substrate specificity. This protein belongs to the Pmr5-Cas1p-esterase subfamily in that it contains the catalytic triad comprised of serine, aspartate and histidine and lacks two conserved regions (glycine after strand S2 and GxND motif). A pseudogene of this gene has been identified on the long arm of chromosome 2. Alternative splicing results in multiple transcript variants that encode different protein isoforms.
Specifications
PCED1A | |
Polyclonal | |
Unconjugated | |
PCED1A | |
A930025D01Rik; AI480484; bA12M19.1; C20orf81; f113a; FAM113A; family with sequence similarity 113, member A; Pced1a; PC-esterase domain containing 1A; PC-esterase domain-containing protein 1A; Protein FAM113A; RGD1308836; Sarcoma antigen NY-SAR-23 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
64773 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.3 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9H1Q7 | |
PCED1A | |
Recombinant protein corresponding to Human PCED1A. Recombinant protein control fragment (Product #RP-99429). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction